胃食管交界癌-话题@MedSci

#胃食管交界癌#

10篇内容 | 735人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1584933, encodeId=6d2f1584933a3, content=<a href='/topic/show?id=e32f83401c1' target=_blank style='color:#2F92EE;'>#胃食管交界癌#</a>, objectTitle=Clin Cancer Res：紫杉醇联合Napabucasin治疗晚期胃/胃食管交界癌, objectType=article, longId=728684, objectId=ddbfe2868440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddbfe2868440, replyNumber=0, likeNumber=35, createdTime=2022-06-07, rootId=0, userName=ms1260584454294838, userId=726e17069198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddbfe2868440, moduleTitle=Clin Cancer Res：紫杉醇联合Napabucasin治疗晚期胃/胃食管交界癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddbfe2868440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584932, encodeId=bfa8158493268, content=<a href='/topic/show?id=e32f83401c1' target=_blank style='color:#2F92EE;'>#胃食管交界癌#</a>, objectTitle=J Clin Oncol：EGFR抑制剂治疗EGFR扩增的胃食管交界癌的疗效, objectType=article, longId=724167, objectId=fa55e2416717, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa55e2416717, replyNumber=0, likeNumber=40, createdTime=2022-04-14, rootId=0, userName=ms1260584454294838, userId=726e17069198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa55e2416717, moduleTitle=J Clin Oncol：EGFR抑制剂治疗EGFR扩增的胃食管交界癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa55e2416717)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584931, encodeId=247215849316c, content=<a href='/topic/show?id=e32f83401c1' target=_blank style='color:#2F92EE;'>#胃食管交界癌#</a>, objectTitle=Lancet Oncol：纳武单抗联合奥沙利铂化疗一线治疗晚期或复发性胃或胃食管交界癌, objectType=article, longId=295669, objectId=d4cf2956690e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4cf2956690e, replyNumber=0, likeNumber=24, createdTime=2022-02-16, rootId=0, userName=ms1260584454294838, userId=726e17069198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4cf2956690e, moduleTitle=Lancet Oncol：纳武单抗联合奥沙利铂化疗一线治疗晚期或复发性胃或胃食管交界癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4cf2956690e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584930, encodeId=f90f1584930f6, content=<a href='/topic/show?id=e32f83401c1' target=_blank style='color:#2F92EE;'>#胃食管交界癌#</a>, objectTitle=NEJM：Nivolumab辅助治疗方案用于晚期食管或胃食管交界癌患者III期临床研究获得成功, objectType=article, longId=209558, objectId=b719209558c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b719209558c2, replyNumber=0, likeNumber=31, createdTime=2021-04-05, rootId=0, userName=ms1260584454294838, userId=726e17069198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b719209558c2, moduleTitle=NEJM：Nivolumab辅助治疗方案用于晚期食管或胃食管交界癌患者III期临床研究获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b719209558c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584929, encodeId=413315849292a, content=<a href='/topic/show?id=e32f83401c1' target=_blank style='color:#2F92EE;'>#胃食管交界癌#</a>, objectTitle=Gastric Cancer：3期| 氟尿嘧啶/噻哌啶治疗转移性胃食管交界癌的疗效, objectType=article, longId=208434, objectId=55c3208434b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55c3208434b1, replyNumber=0, likeNumber=31, createdTime=2021-03-17, rootId=0, userName=ms1260584454294838, userId=726e17069198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55c3208434b1, moduleTitle=Gastric Cancer：3期| 氟尿嘧啶/噻哌啶治疗转移性胃食管交界癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55c3208434b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584928, encodeId=f28615849287b, content=<a href='/topic/show?id=e32f83401c1' target=_blank style='color:#2F92EE;'>#胃食管交界癌#</a>, objectTitle=Clin Cancer Res：派姆单抗单药治疗PD-L1联合阳性评分≥10的胃/胃食管交界癌的疗效, objectType=article, longId=207294, objectId=4f3f20e2949c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f3f20e2949c, replyNumber=0, likeNumber=43, createdTime=2021-02-20, rootId=0, userName=ms1260584454294838, userId=726e17069198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f3f20e2949c, moduleTitle=Clin Cancer Res：派姆单抗单药治疗PD-L1联合阳性评分≥10的胃/胃食管交界癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f3f20e2949c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584927, encodeId=6377158492ed6, content=<a href='/topic/show?id=e32f83401c1' target=_blank style='color:#2F92EE;'>#胃食管交界癌#</a>, objectTitle=Lancet oncol：曲妥珠单抗deruxtecan用于HER2阳性的胃或胃食管交界癌的疗效和安全性, objectType=article, longId=165380, objectId=4e2c165380ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e2c165380ae, replyNumber=0, likeNumber=32, createdTime=2019-05-06, rootId=0, userName=ms1260584454294838, userId=726e17069198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e2c165380ae, moduleTitle=Lancet oncol：曲妥珠单抗deruxtecan用于HER2阳性的胃或胃食管交界癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e2c165380ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584926, encodeId=d554158492688, content=<a href='/topic/show?id=e32f83401c1' target=_blank style='color:#2F92EE;'>#胃食管交界癌#</a>, objectTitle=CLIN CANCER RES：SHR-1210联合阿帕替尼治疗晚期肝细胞癌、胃癌或胃食管交界癌, objectType=article, longId=159011, objectId=865615901193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=865615901193, replyNumber=0, likeNumber=36, createdTime=2019-01-28, rootId=0, userName=ms1260584454294838, userId=726e17069198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=865615901193, moduleTitle=CLIN CANCER RES：SHR-1210联合阿帕替尼治疗晚期肝细胞癌、胃癌或胃食管交界癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=865615901193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584925, encodeId=70cf15849250e, content=<a href='/topic/show?id=e32f83401c1' target=_blank style='color:#2F92EE;'>#胃食管交界癌#</a>, objectTitle=Lancet Oncol：曲妥珠单抗+帕妥珠单抗+化疗不能延长HER2阳性转移性胃或胃食管交界癌患者总生存期, objectType=article, longId=148716, objectId=1eac148e167e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eac148e167e, replyNumber=0, likeNumber=36, createdTime=2018-09-14, rootId=0, userName=ms1260584454294838, userId=726e17069198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eac148e167e, moduleTitle=Lancet Oncol：曲妥珠单抗+帕妥珠单抗+化疗不能延长HER2阳性转移性胃或胃食管交界癌患者总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eac148e167e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1584924, encodeId=bcd91584924bd, content=<a href='/topic/show?id=e32f83401c1' target=_blank style='color:#2F92EE;'>#胃食管交界癌#</a>, objectTitle=Lancet：派姆单抗单药二线治疗胃以及胃食管交界癌效果不佳, objectType=article, longId=140045, objectId=0720140045ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0720140045ca, replyNumber=0, likeNumber=35, createdTime=2018-06-07, rootId=0, userName=ms1260584454294838, userId=726e17069198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0720140045ca, moduleTitle=Lancet：派姆单抗单药二线治疗胃以及胃食管交界癌效果不佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0720140045ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

胃食管交界癌

2020-05-29

ms1260584454294838 (审核中...)

前往app查看评论内容

#胃食管交界癌#

Clin Cancer Res：紫杉醇联合Napabucasin治疗晚期胃/胃食管交界癌

2022-06-07

ms1260584454294838 (审核中...)

前往app查看评论内容

#胃食管交界癌#

J Clin Oncol：EGFR抑制剂治疗EGFR扩增的胃食管交界癌的疗效

2022-04-14

ms1260584454294838 (审核中...)

前往app查看评论内容

#胃食管交界癌#

Lancet Oncol：纳武单抗联合奥沙利铂化疗一线治疗晚期或复发性胃或胃食管交界癌

2022-02-16

ms1260584454294838 (审核中...)

前往app查看评论内容

#胃食管交界癌#

NEJM：Nivolumab辅助治疗方案用于晚期食管或胃食管交界癌患者III期临床研究获得成功

2021-04-05

ms1260584454294838 (审核中...)

前往app查看评论内容

#胃食管交界癌#

Gastric Cancer：3期| 氟尿嘧啶/噻哌啶治疗转移性胃食管交界癌的疗效

2021-03-17

ms1260584454294838 (审核中...)

前往app查看评论内容

#胃食管交界癌#

Clin Cancer Res：派姆单抗单药治疗PD-L1联合阳性评分≥10的胃/胃食管交界癌的疗效

2021-02-20

ms1260584454294838 (审核中...)

前往app查看评论内容

#胃食管交界癌#

Lancet oncol：曲妥珠单抗deruxtecan用于HER2阳性的胃或胃食管交界癌的疗效和安全性

2019-05-06

ms1260584454294838 (审核中...)

前往app查看评论内容

#胃食管交界癌#

CLIN CANCER RES：SHR-1210联合阿帕替尼治疗晚期肝细胞癌、胃癌或胃食管交界癌

2019-01-28

ms1260584454294838 (审核中...)

前往app查看评论内容

#胃食管交界癌#

Lancet Oncol：曲妥珠单抗+帕妥珠单抗+化疗不能延长HER2阳性转移性胃或胃食管交界癌患者总生存期

2018-09-14

ms1260584454294838 (审核中...)

前往app查看评论内容

#胃食管交界癌#

Lancet：派姆单抗单药二线治疗胃以及胃食管交界癌效果不佳

2018-06-07

科室
- - 订阅+
  - 更多科室
工具
服务